文献速递其他结缔组织病

系统性硬化症患者胃肠道进展的独特临床轨迹

Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究在2696例至少有两次改良Medsger胃肠道严重度评分的系统性硬化症患者中,采用生长混合模型识别出四种胃肠道表型:稳定型(n=2325)、早期进展型(n=142)、晚期进展型(n=115)和早期严重胃肠道型(n=114)。这些表型不仅可通过胃肠道及肠外临床并发症区分,还具有时间上的差异,且不同自身抗体谱与更严重的胃肠道疾病强烈相关。

要点

  • 在2696例系统性硬化症患者中识别出四种胃肠道进展表型:稳定型、早期进展型、晚期进展型和早期严重胃肠道型。
  • 最常见的稳定型(n=2325)平均评分持续为1分;早期进展型(n=142)和晚期进展型(n=115)初始平均评分均为1分,前者先升高后稳定,后者随时间缓慢恶化。
  • 早期严重胃肠道型(n=114)初始平均Medsger胃肠道评分略低于3分,死亡率高且胃肠道严重度随时间改善。

核心结论

  • 系统性硬化症患者中存在临床不同的胃肠道表型,这些表型不仅通过胃肠道和肠外系统性硬化症临床并发症区分,而且在时间上也有差异。
  • 不同的自身抗体谱与更严重的胃肠道疾病强烈相关。

研究设计与样本

  • 研究纳入一个成熟建立且特征明确的系统性硬化症患者队列,使用改良Medsger胃肠道严重度评分进行纵向测量。
  • 采用生长混合模型估计每例患者的表型和疾病严重度随时间变化的轨迹。
  • 使用非参数统计以及线性和逻辑回归比较估计表型的特征,并在校正疾病病程后比较表型间的患者特征。
  • 共分析2696例至少具有两次Medsger胃肠道评分的系统性硬化症患者。

主要发现

  • 识别出四种独特表型:最常见为稳定型(n=2325),平均评分持续为1分。
  • 早期进展型(n=142)和晚期进展型(n=115)初始平均评分均为1分;早期进展型初期升高后稳定,晚期进展型随时间缓慢恶化。
  • 早期严重胃肠道型(n=114)初始平均Medsger胃肠道评分略低于3分,死亡率高且胃肠道严重度随时间改善。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Systemic sclerosis (SSc) is heterogeneous in its clinical presentation. Common manifestations cluster together, defining unique subgroups. This investigation aims to characterize gastrointestinal (GI) phenotypes and determine whether they can be distinguished by temporal progression. METHODS: We examined a well-established SSc patient cohort with a modified Medsger GI severity score measured over time to determine heterogeneity in disease progression. Growth mixture models estimated each patient's phenotype and disease severity trajectory over time. We compared the characteristics of estimated phenotypes using non-parametric statistics and linear and logistic regression to compare patient characteristics between phenotypes while adjusting for disease duration. RESULTS: We examined 2696 SSc patients with at least two Medsger GI scores, identifying four unique phenotypes. The most common phenotype ('Stable', n = 2325) had an average score of 1 that was consistent over time. Two phenotypes were progressive ('Early Progressive', n = 142, and 'Late Progressive', n = 115) with an initial average score of 1. The Early Progressive group increased initially and stabilized, and the Late Progressive group worsened slowly over time. A fourth phenotype ('Early Severe GI', n = 114) had an initial average Medsger GI score just below 3 with high mortality and improving GI severity over time. CONCLUSIONS: Clinically distinct GI phenotypes exist among patients with SSc. These phenotypes are not only distinguished by GI and extra-intestinal SSc clinical complications, but they are also temporally distinct. Distinct autoantibody profiles are associated strongly with more severe GI disease.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Perin J, Hughes M, Mecoli CA, et al. Distinct clinical trajectories of gastrointestinal progression among patients with systemic sclerosis. Rheumatology (Oxford). 2025. PMID: 39213328. doi:10.1093/rheumatology/keae469

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。